Armistice Capital, Llc - Net Worth and Insider Trading
Armistice Capital, Llc Net Worth
The estimated net worth of Armistice Capital, Llc is at least $38 Million dollars as of 2024-05-15. Armistice Capital, Llc is the 10% Owner of Del Frisco′s Restaurant Group Inc and owns about 4,628,000 shares of Del Frisco′s Restaurant Group Inc (DFRG) stock worth over $37 Million. Armistice Capital, Llc is the 10% Owner of Reshape Lifesciences Inc and owns about 211,746 shares of Reshape Lifesciences Inc (RSLS) stock worth over $584,419. Armistice Capital, Llc is also the Director, 10% Owner of Avalo Therapeutics Inc and owns about 6,309 shares of Avalo Therapeutics Inc (AVTX) stock worth over $66,875. Details can be seen in Armistice Capital, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Armistice Capital, Llc has not made any transactions after 2021-06-18 and currently still holds the listed stock(s).
Transaction Summary of Armistice Capital, Llc
Armistice Capital, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Armistice Capital, Llc owns 21 companies in total, including Cyclo Therapeutics Inc (CYTH) , Reshape Lifesciences Inc (RSLS) , and Tenax Therapeutics Inc (TENX) among others .
Click here to see the complete history of Armistice Capital, Llc’s form 4 insider trades.
Insider Ownership Summary of Armistice Capital, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2020-08-27 | 10 percent owner |
| RSLS | Reshape Lifesciences Inc | 2021-06-18 | 10 percent owner |
| TENX | Tenax Therapeutics Inc | 2021-07-08 | director |
 | | 2021-08-16 | director & 10 percent owner |
| | 2020-07-28 | director & 10 percent owner |
| | 2019-09-26 | 10 percent owner |
| | 2019-02-05 | 10 percent owner |
| | 2020-03-16 | 10 percent owner |
| | 2020-02-14 | 10 percent owner |
| | 2021-07-27 | director & 10 percent owner |
| | 2019-12-20 | 10 percent owner |
| | 2019-09-25 | 10 percent owner |
| | 2019-09-23 | 10 percent owner |
| | 2019-05-30 | 10 percent owner |
| | 2019-01-18 | 10 percent owner |
| | 2018-01-22 | 10 percent owner |
| | 2018-08-15 | 10 percent owner |
| | 2018-09-20 | 10 percent owner |
| | 2018-02-02 | 10 percent owner |
| | 2017-03-21 | 10 percent owner |
| | 2021-06-15 | 10 percent owner |
Armistice Capital, Llc Latest Holdings Summary
Armistice Capital, Llc currently owns a total of 3 stocks. Among these stocks, Armistice Capital, Llc owns 4,628,000 shares of Del Frisco′s Restaurant Group Inc (DFRG) as of January 11, 2019, with a value of $37 Million and a weighting of 98.27%. Armistice Capital, Llc owns 211,746 shares of Reshape Lifesciences Inc (RSLS) as of June 18, 2021, with a value of $584,419 and a weighting of 1.56%. Armistice Capital, Llc also owns 6,309 shares of Avalo Therapeutics Inc (AVTX) as of January 11, 2019, with a value of $66,875 and a weighting of 0.18%.
Latest Holdings of Armistice Capital, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DFRG | Del Frisco′s Restaurant Group Inc | 2019-01-11 | 4,628,000 | 7.98 | 36,931,440 |
| RSLS | Reshape Lifesciences Inc | 2021-06-18 | 211,746 | 2.76 | 584,419 |
| AVTX | Avalo Therapeutics Inc | 2019-01-11 | 6,309 | 10.60 | 66,875 |
Holding Weightings of Armistice Capital, Llc
Armistice Capital, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Armistice Capital, Llc has made a total of 0 transactions in Del Frisco′s Restaurant Group Inc (DFRG) over the past 5 years. The most-recent trade in Del Frisco′s Restaurant Group Inc is the acquisition of 44,100 shares on January 11, 2019, which cost Armistice Capital, Llc around $361,179.
According to the SEC Form 4 filings, Armistice Capital, Llc has made a total of 1 transactions in Reshape Lifesciences Inc (RSLS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Reshape Lifesciences Inc is the sale of 2,303,469 shares on June 18, 2021, which brought Armistice Capital, Llc around $14 Million.
According to the SEC Form 4 filings, Armistice Capital, Llc has made a total of 0 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 5 shares on January 11, 2019, which cost Armistice Capital, Llc around $54,305.
Insider Trading History of Armistice Capital, Llc
- 1
Armistice Capital, Llc Trading Performance
GuruFocus tracks the stock performance after each of Armistice Capital, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Armistice Capital, Llc is 12.64%. GuruFocus also compares Armistice Capital, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Armistice Capital, Llc within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Armistice Capital, Llc's insider trading performs compared to the benchmark.
Performance of Armistice Capital, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.11 | | | | | |
| Relative Return to S&P 500(%) | 12.1 | | | | | |
Armistice Capital, Llc Ownership Network
Armistice Capital, Llc Owned Company Details
What does Cyclo Therapeutics Inc do?
Who are the key executives at Cyclo Therapeutics Inc?
Armistice Capital, Llc is the 10 percent owner of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , director & Chief Executive Officer Jeffrey Tate , and SVP for Medical Affairs Sharon Hemond Hrynkow .
Cyclo Therapeutics Inc (CYTH) Insider Trades Summary
Over the past 18 months, Armistice Capital, Llc made no insider transaction in Cyclo Therapeutics Inc (CYTH). Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. , a net purchase of 299,402 shares made by N Scott Fine , and a net purchase of 59,881 shares made by Markus Sieger .
In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,449,105 shares were bought by its insiders, resulting in a net purchase of 4,449,105 shares.
Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclo Therapeutics Inc Insider Transactions
Armistice Capital, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Armistice Capital, Llc. You might contact Armistice Capital, Llc via mailing address: 510 Madison Avenue, 7th Floor, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
